MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

Strona główna・Stock List・Harmony Biosciences Holdings Inc

Search

Harmony Biosciences Holdings Inc

Closed

SectorHealthcare

29.43 -1.83

Overview

Share price change

24h

Current

Min

28.61

Max

29.85

Key metrics
By Trading Economics
Income	-28M 22M
Sales	4.3M 244M
P/E Sector Avg	10.72 63.808
Profit margin	9.224
Employees	293
EBITDA	-22M 52M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+37.55% upside

Dividends
By Dow Jones
Next Earnings	5 maj 2026

Market Stats
By TradingEconomics
Market Cap	133M 1.7B
Previous open	31.26
Previous close	29.43

News Sentiment

By Acuity

100%

0%

337 / 348 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Weak Bullish Evidence

29.8 / N/A Support & Resistance

Harmony Biosciences Holdings Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

20 kwi 2026, 23:49 UTC

Major News Events

New Zealand 1Q Inflation Higher Than Expected

20 kwi 2026, 23:10 UTC

Hot Stocks

Stocks to Watch: Amazon, Alaska Air Group, BridgeBio Oncology, AXT

20 kwi 2026, 22:53 UTC

Major Market Movers

BridgeBio Oncology Shares Rise After FDA Fast-Tracks Pancreatic Cancer Treatment

20 kwi 2026, 23:45 UTC

Market Talk

Nikkei May Rise on Hopes for U.S.-Iran Peace Talks -- Market Talk

20 kwi 2026, 23:44 UTC

Market Talk

Gold Consolidates as End of Cease-Fire Looms -- Market Talk

20 kwi 2026, 23:39 UTC

Market Talk

Rio Tinto Posts Strong Start to Year -- Market Talk

20 kwi 2026, 23:30 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

20 kwi 2026, 23:30 UTC

Market Talk

Global Equities Roundup: Market Talk

20 kwi 2026, 23:30 UTC

Market Talk

Super Retail's Earnings Outlook Less Rosy -- Market Talk

20 kwi 2026, 23:09 UTC

Market Talk

Viva Energy's Refinery Fire More Benign Than Jefferies Thought -- Market Talk

20 kwi 2026, 22:31 UTC

Acquisitions, Mergers, Takeovers

Anthropic, Amazon Tighten Bond in $5 Billion Investment and Computing Deal -- WSJ

20 kwi 2026, 22:26 UTC

Acquisitions, Mergers, Takeovers

West African Resources Says Sanbrado, Toega Operations Not Subject to Govt Request for Additional Participation

20 kwi 2026, 22:25 UTC

Acquisitions, Mergers, Takeovers

West African Resources Plans to Distribute Cash Proceeds to Shareholders Via Special Dividend

20 kwi 2026, 22:25 UTC

Acquisitions, Mergers, Takeovers

West African Resources Aims for Acquisition to Be Completed by End-2026

20 kwi 2026, 22:25 UTC

Acquisitions, Mergers, Takeovers

West African Resources Says to Work Cooperatively With Govt to Finalize Deal Terms

20 kwi 2026, 22:25 UTC

Acquisitions, Mergers, Takeovers

West African Resources Says Acquisition Would Be for A$175 Million

20 kwi 2026, 22:24 UTC

Acquisitions, Mergers, Takeovers

West African Resources Says Burkina Faso Govt Issues Decree to Acquire 25% of Kiaka

20 kwi 2026, 22:15 UTC

Acquisitions, Mergers, Takeovers

Anthropic, Amazon Tighten Bond in $5 Billion Investment and Computing Deal -- WSJ

20 kwi 2026, 22:01 UTC

Acquisitions, Mergers, Takeovers

Amazon Invests $5B in Anthropic Amid Expanded Collaboration

20 kwi 2026, 21:38 UTC

Market Talk

Apple's New CEO Will Face Immediate Pressure on AI Strategy -- Market Talk

20 kwi 2026, 21:33 UTC

Acquisitions, Mergers, Takeovers

Uber Expands Stake In Lucid for Robo-Taxis. This Is How Tesla's Stock Is Responding. -- Barrons.com

20 kwi 2026, 21:24 UTC

Market Talk

Apple's CEO Change Timing Will Garner Mixed Reaction, Analyst Says -- Market Talk

20 kwi 2026, 21:24 UTC

Market Talk

Global Equities Roundup: Market Talk

20 kwi 2026, 21:13 UTC

Earnings

Alaska Air: Expansion of Card Portfolio Expected to Accelerate Loyalty Platform Beyond Incremental $150M Profit Outlined in Alaska Accelerate Strategy

20 kwi 2026, 21:10 UTC

Earnings

Alaska Air to Move Toward a Single Issuer for Atmos Rewards Credit Cards

20 kwi 2026, 21:09 UTC

Earnings

Alaska Air Sees 2Q Capacity Up About 1% Year-Over-Year, Down Nearly a Point From Original Views, on 'Proactive Trimming' of May and June Capacity

20 kwi 2026, 21:08 UTC

Earnings

Alaska Air 'Continues to Operate From a Position of Strength,' With Healthy Balance Sheet, Strong Liquidity, About $20B in Unencumbered Assets

20 kwi 2026, 21:07 UTC

Earnings

Alaska Air: Taken Together, Rev, Cost and Fuel Assumptions Result in 2Q Adjusted Loss Per Share Estimate of About $1

20 kwi 2026, 21:05 UTC

Earnings

Alaska Air: This Assumption Adds About $600M of Expense to 2Q, Equivalent to EPS Headwind of $3.60

20 kwi 2026, 21:05 UTC

Earnings

Alaska Air Expects 2Q Fuel Cost to Average About $4.50 Based on Forward Curve Today

Peer Comparison

Price change

Harmony Biosciences Holdings Inc Forecast

Price Target

By TipRanks

37.55% upside

12 Months Forecast

Average 41.25 USD 37.55%

High 62 USD

Low 25 USD

Based on 8 Wall Street analysts offering 12 month price targets forHarmony Biosciences Holdings Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

8 ratings

4

Buy

3

Hold

1

Sell

Based on 8 analysts giving stock ratings to Harmony Biosciences Holdings Inc - Dist in the past 3 months.

Technical Score

By Trading Central

29.8 / N/ASupport & Resistance

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Sentiment

By Acuity

337 / 348 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.

Other stocks from the sector

MDT

Medtronic PLC

85.26

A

Agilent Technologies Inc

120.85

VEEV

Veeva Systems Inc

168.97

HQY

HealthEquity Inc

86.11

NEOG

Neogen Corp

9.63

Live chat